HU6

Ascending Dose Study of HU6 in Healthy Volunteers

Multiple Ascending Dose Study of HU6 in High BMI Volunteers

Phase 1, Open-Label, Randomized, Study of the Safety and Pharmacokinetics of HU6

Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers

Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)